当前位置: X-MOL 学术Proc. Natl. Acad. Sci. U.S.A. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
An intermediate-effect size variant in UMOD confers risk for chronic kidney disease
Proceedings of the National Academy of Sciences of the United States of America ( IF 11.1 ) Pub Date : 2022-08-10 , DOI: 10.1073/pnas.2114734119
Eric Olinger 1, 2 , Céline Schaeffer 3 , Kendrah Kidd 4, 5 , Elhussein A E Elhassan 6, 7 , Yurong Cheng 8, 9 , Inès Dufour 1, 10 , Guglielmo Schiano 1 , Holly Mabillard 2, 11 , Elena Pasqualetto 3 , Patrick Hofmann 1 , Daniel G Fuster 12 , Andreas D Kistler 13 , Ian J Wilson 14 , Stanislav Kmoch 4, 5 , Laure Raymond 15 , Thomas Robert 16, 17 , , Kai-Uwe Eckardt 18, 19 , Anthony J Bleyer 4, 5 , Anna Köttgen 8, 20 , Peter J Conlon 6, 7 , Michael Wiesener 19 , John A Sayer 2, 11, 21 , Luca Rampoldi 3 , Olivier Devuyst 1, 10
Affiliation  

Proceedings of the National Academy of Sciences, Volume 119, Issue 33, August 2022.


中文翻译:

UMOD 的中间效应大小变异会带来慢性肾病的风险

《美国国家科学院院刊》,第 119 卷,第 33 期,2022 年 8 月。
更新日期:2022-08-10
down
wechat
bug